Antidotes (Exam 1 Cut Off) Flashcards

1
Q

Properties of Ideal Antidote

A
  • Completely reverses or neutralizes the effects of the poison
  • No action of its own
  • Easy to administer
  • No unpleasant SE
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Chelators

A
  • EX: Dimercaprol (BAL), penicillamine, DMSA, EDTA, Deferoxamine (used for Fe)
  • BAL: pain, peanut allergy
  • EDTA: nephrotoxicity
  • Deferoxamine: hypotension, anaphylactoid rxn, ARDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Chronic Lead Poisoning

A
  • KUB: gastric lavage
  • Whole bowel irrigation
  • Aggressive hydration
  • BAL: 4-5 mg/kg IM 4h if Pb >= 70 mcg/dL
  • PO DMSA + IV EDTA preferred
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Iron Chelation

A
  • Deferoxamine colorless compound when Fe+3 is removed
  • Avidly binds to iron form ferrioxamine
  • Eliminated urine is “pink rose” color - endpoint of therapy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Iron Poisoning

A
  • KUB for retained pills
  • Fe++ > 500 mcg/dL or > 350 mcg/dL with symptoms
  • WBC > 15, BS > 150
  • TIBC useless
  • Lavage? WBI, aggressive fluids
  • IV Deferoxamine 15 mg/kg/hour, NMT 24 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Antivenins/Biologics

A
  • Crotalidae Antivenin: rattlesnake
  • Lactrodectus Antivenin: black widow spider
  • Elapidae antivenin: eastern/texan coral snake
  • Trivalent botulinum: Botulism types A, B, and E
  • Digoxin Immune Fab: digoxin/digitoxin poisoning
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Digoxin Immune Fab Indications/Dosing

A
  • K > 5.5 mEq/L, progressive heart block, Ventricular dysrhytmias, CV collapse
  • Dose >= 10 mg in adults of 0.1 mg/kg in children
  • # vials = serum levels x weight in kg/100
  • Must measure > 6 hours after last dose OR # vials = dose in mg/0.5 mg/vial
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

N-acetylcysteine

A
  • For APAP Poisoning

- Prevents NAPQI binding at hepatocyte

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Naloxone

A
  • For Opioid poisoning

- Opioid receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Flumazenil

A
  • For Benzo poisoning
  • Benzo receptor antagonist
  • Can be CI due to risk of seizures, reversing dependence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Atropine

A
  • For OP and carblnsecticides poison

- Muscarinic receptor antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Fomepizole

A
  • For Methanol and ethylene glycol poisoning
  • Blocks metabolite formation
  • Potential ADH competitive inhibitor
  • Prolongs half life, methanol from 20 to 54 hours, and ethylene glycol from 4 to 20 hours
  • Often need hemodialysis for methanol
  • Dose: 15 mg/kg IV then 10 mg/kg q12h x 4 doses, then 15 mg/kg q12h
  • If hemodialysis is needed, give every 4 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Idarucizumab

A
  • For dagibatran poisoning

- Monoclonal antibody

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coagulation Factor XA recombinant

A
  • For apixaban/rivaroxaban poisoning

- Binds and sequesters Xa inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Prussian Blue

A
  • For thalium cesium isotopes poisoning

- Binds and inactivates thallium and cesium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Glucarpidase

A
  • For methotrexate poisoning

- Enzymatic cleavage of methotrexate

17
Q

Silymarin

A
  • For amantoxin poisoning

- Unclear mechanism, but likely antioxidant

18
Q

Nomogram

A
  • Cannot plot a level prior to 4 hours: starts at elimination phase and peak level is 1-2 hours
  • Cannot plot chronic supratherapeutic levels
  • Slope is based on 4 hour half-life: most have a shorter one
  • Toxic 4 hour level is 150 mcg/mL: mental math for other times (8 = 75, 12 = 37.5, etc.)
19
Q

Anaphylactoid Rxn Risk

A
  • More common in lower APAP levels
  • 25% if APAP < 150, but only 3% if APAP > 300
  • APAP decreases histamine release from mononucleocytes and mast cell (dose-dependent)
20
Q

Antidotes + Preventing Hypoglycemia + Sulfonylurea Overdose

A
  • Oral dextrose
  • IV dextrose
  • Sumatriptan
  • Octreotide
21
Q

Why glucose fluctuations?

A
  • Duration of drug longer than duration of glucose
  • Glucose enters the beta cell without insulin
  • Sulfonylurea blocks closure of K-ATP channel
  • Additional glucose yields additional insulin
22
Q

Octreotide

A

-Somatostatin analog, blocks beta-cell calcium channels to reduce insulin secretion
Doses
-Children: 1-1.5 mcg/kg IV or SC followed by 2-3 more doses 6 hours apart
-Adult: 50-100 mcg SQ or IV, followed by three 50 mcg doses every 6 hours
-During treatment, IV dextrose infusion should be gradually tapered off

23
Q

HIE Therapy Maintenance

A
  • High dose insulin euglycemia
  • Insulin: 1 unit/kg/hour, increasing by 0.5 unit/kg/hour every 30 minutes up to max of 15
  • Titrate to BP (MAP >= 60), no effect on HR
  • Use concentrated as 5,000u in 500 mL NS
  • Glucose bolus of 0.25 g/kg if glucose <200
  • Start D5W or D10W at 0.15 g/h
  • Maintain serum K+ at 2.5-2.8 mEq/L, permissive hypokalemia might be helpful
24
Q

HIE Pitfalls

A
  • Stopping insulin before stopping pressor: pressor-sparing
  • Stopping insulin and glucose at the same time: continue glucose 24-36 hours after D/C insulin
  • volume overload if insulin is dilute
25
Q

L-Carnitine Rational

A
  • High first pass, only 15% oral bioavailability
  • Manufacturer suggests q3-4h, never q<6h
  • Mechanism: clears acyl CoA esters by forming acylcarnitine, shifts metabolism of VPA away from hepatoxic metabolites
  • Reverses acquired urea cycle defect, resolving hyperammonemia
26
Q

L-Carnitine Indications

A
  • Serum VPA > 450 mcg/mL
  • Severe coma
  • Hyperammonemia (>80 mcg/dL)
  • CCB overdose refractory to pressors and HEI: increases calcium channel sensitivity, decreases insulin resistance, facilitates metabolism of FFAi